Cancer Chemother Pharmacol
October 2024
Purpose: Cancer stem cells (CSCs) account for recurrence and resistance to breast cancer drugs, rendering them a cause of mortality and therapeutic failure. In this study, we examined the effects of exposure to low concentrations of doxorubicin (Dox) on CSCs and non-CSCs from TNBC.
Methods: The effects of Dox were studied using the SORE6 reporter system.